The Food and Drug Administration (FDA) has granted approval for emergency use of the anti-malaria drug chloroquine, or hydroxychloroquine as it’s sometimes called, to treat COVID-19, the respiratory illness derived from the novel coronavirus, Yahoo Finance reports. Anecdotal evidence suggests that the drug may be useful in treating the disease in some cases.
Anecdotal evidence has suggested that some patients with COVID-19 can get relief from the decades-old anti-malaria drug.
“Anecdotal reports suggest that these drugs may offer some benefit in the treatment of hospitalized COVID-19 patients. Clinical trials are needed to provide scientific evidence that these treatments are effective,” according to a statement from the Department of Health and Human Services (HHS).
However, clinical trials must be conducted under tight scientific controls, and the process can take months or years.
But with the coronavirus pandemic currently spreading across the United States, currently ravaging New York City and becoming a bigger problem by the day in Detroit and New Orleans, time is short.
0 comments :
Post a Comment